No photo of James R Johnson
Contact Expert

View Scopus Profile

James R Johnson

1977 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 12 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Study of persistence of intestinal colonization with E.

Johnson, J. R.

Duke University

12/1/16 → 11/30/18

Project: Research project

    • Clonotyping Technology for Prediction of Antibiotic Resi

    Johnson, J. R.

    ID GENOMICS INC.

    5/1/16 → 1/30/20

    Project: Research project

    • Infectious Disease Training in Clinical Investigation

    Boulware, D. R., Boulware, D. R. & Johnson, J. R.

    NIH Nat'l Inst of Allergy & Infect Dis

    7/1/15 → 6/30/20

    Project: Research project

    E. coli ST131-H30 colonization: defining community and p

    Johnson, J. R.

    THE GEORGE WASHINGTON UNIVERSITY

    2/20/15 → 1/31/17

    Project: Research project

    • Effectiveness of Screening and Decolonization of S. aure

    Kline, S. E., Ferrieri, P., Johnson, J. R., Kulasingam, S. L. & Neaton, J.

    U.S. DEPT OF HEALTH & HUMAN SERV AHRQ

    7/1/14 → 6/1/16

    Project: Research project

    • Research Output

    Activity of ceftazidime-avibactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status

    Johnston, B. D., Thuras, P. D. & Johnson, J. R., Jul 2020, In : Diagnostic Microbiology and Infectious Disease. 97, 3, 115034.

    Research output: Contribution to journal › Article

    • Activity of imipenem-relebactam against carbapenem-resistant Escherichia coli isolates from the United States in relation to clonal background, resistance genes, coresistance, and region

    Johnston, B. D., Thuras, P., Porter, S. B., Anacker, M., VonBank, B., Vagnone, P. S., Witwer, M., Castanheira, M. & Johnson, J. R., May 2020, In : Antimicrobial agents and chemotherapy. 64, 5, e02408-19.

    Research output: Contribution to journal › Article

    • Despite predominance of uropathogenic/extraintestinal pathotypes among travel-acquired extended-spectrum β-lactamase-producing Escherichia coli, the most commonly associated clinical manifestation is travelers' diarrhea

    Kantele, A., Lääveri, T., Mero, S., Häkkinen, I. M. K., Kirveskari, J., Johnston, B. D. & Johnson, J. R., Jan 15 2020, In : Clinical Infectious Diseases. 70, 2, p. 210-2185 1976 p.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations

    Emergence of enteroaggregative escherichia coli within the ST131 lineage as a cause of extraintestinal infections

    Boll, E. J., Overballe-Petersen, S., Hasman, H., Roer, L., Ng, K., Scheutz, F., Hammerum, A. M., Dungu, A., Hansen, F., Johannesen, T. B., Johnson, A., Nair, D. T., Lilje, B., Hansen, D. S., Krogfelt, K. A., Johnson, T. J., Price, L. B., Johnson, J. R., Struve, C., Olesen, B. & 1 others, Stegger, M., 2020, In : mBio. 11, 3, e00353-20.

    Research output: Contribution to journal › Article

    Open Access

    • Genomic analysis of fluoroquinolone-susceptible phylogenetic group B2 extraintestinal pathogenic Escherichia coli causing infections in cats

    Kidsley, A. K., O'Dea, M., Ebrahimie, E., Mohammadi-Dehcheshmeh, M., Saputra, S., Jordan, D., Johnson, J. R., Gordon, D., Turni, C., Djordjevic, S. P., Abraham, S. & Trott, D. J., Jun 2020, In : Veterinary Microbiology. 245, 108685.

    Research output: Contribution to journal › Article

    • Press / Media

    Going vegetarian may lower risk of UTIs in women, study finds

    James R Johnson

    1/30/20

    1 item of Media coverage

    Press/Media: Expert Comment